Show simple item record

dc.contributor.author García Lescano, Héctor Hugo
dc.date.accessioned 2018-11-30T22:50:33Z
dc.date.available 2018-11-30T22:50:33Z
dc.date.issued 2018
dc.identifier.uri https://hdl.handle.net/20.500.12866/4134
dc.description.abstract Neurocysticercosis (NCC) is a major contributor to the burden of seizure disorders and epilepsy in most of the world. NCC encompasses a variety of clinical presentations, depending on number, location, size, evolutionary stage of lesions, and the inflammatory response of the host, with late-onset seizures, headache, and intracranial hypertension the most frequent manifestations. Diagnosis and therapy depend on the type of NCC, considering its location and stage of the lesions. Medical therapy for NCC should be oriented to obtain appropriate symptom control and then use of antiparasitic agents considered. Antiparasitic treatment is of benefit in most cases of viable and degenerating NCC. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Neurologic Clinics
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Neurocysticercosis en_US
dc.subject Albendazole en_US
dc.subject Cysticercosis en_US
dc.subject Epilepsy en_US
dc.subject Nervous system infections en_US
dc.subject Praziquantel en_US
dc.subject Taenia solium en_US
dc.title Neurocysticercosis en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/j.ncl.2018.07.003
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.25
dc.relation.issn 1557-9875


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


Browse

My Account

Statistics